Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Male
Carcinoma, Hepatocellular
Science
Q
Liver Neoplasms
R
610
Middle Aged
Prognosis
3. Good health
03 medical and health sciences
0302 clinical medicine
Medicine
Humans
Female
Chemoembolization, Therapeutic
Research Article
Aged
DOI:
10.1371/journal.pone.0180408
Publication Date:
2017-07-03T17:37:11Z
AUTHORS (11)
ABSTRACT
Various noninvasive liver reserve markers were proposed to indicate the severity of damage. However, role and feasibility these predict prognosis patients with hepatocellular carcinoma (HCC) are unknown. We aimed identify prognostic 8 currently used hepatic in HCC undergoing transarterial chemoembolization (TACE).Between 2002 2013, a total 881 TACE prospectively identified retrospectively analyzed. The baseline characteristics, tumor status collected. Homogeneity corrected Akaike information criteria (AICc) compared between markers. Cox proportional hazards model was independent predictors survival.Significant differences survival distribution found for albumin-bilirubin (ALBI) grade, Child-Turcotte-Pugh (CTP) class, Lok index, fibrosis index based on 4 factors (FIB-4), Göteborg University cirrhosis (GUCI), discriminant (CDI) end-stage disease (MELD) score (all p values <0.05). Among markers, ALBI grade showed highest homogeneity lowest AICc value, indicating better performance. multivariate analysis confirmed that 2, ascites, serum alkaline phosphatase α-fetoprotein level, diameter, vascular invasion performance significant predictors. well correlated CTP MLED scores.Our data suggest among may serve as an objective feasible surrogate TACE.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (33)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....